{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:46:03Z","timestamp":1793807163104,"version":"4.6.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.berh.2024.101984","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T02:56:09Z","timestamp":1722048969000},"page":"101984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["A lifelong journey: Long-term perspectives on Juvenile Idiopathic Arthritis"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7132-8909","authenticated-orcid":false,"given":"Filipa","family":"Oliveira Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Zinterl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Eurico","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.berh.2024.101984_bib1","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"issue":"9783","key":"10.1016\/j.berh.2024.101984_bib2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.berh.2024.101984_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/03009742.2018.1475580","article-title":"Healthcare costs and outcomes in adult patients with juvenile idiopathic arthritis: a population-based study","volume":"48","author":"Mars","year":"2019","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/acr.24857","article-title":"Changing patterns in treatment, remission status, and categories in a long-term nordic cohort study of juvenile idiopathic arthritis","volume":"74","author":"Glerup","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12969-022-00742-2","article-title":"Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience","volume":"20","author":"Mikola","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/nop2.164","article-title":"Transition from child to adult care in an outpatient clinic for adolescents with juvenile idiopathic arthritis: an inductive qualitative study","volume":"5","author":"Raunsb\u00e6k Knudsen","year":"2018","journal-title":"Nurs Open"},{"issue":"7","key":"10.1016\/j.berh.2024.101984_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/1054-139X(93)90143-D","article-title":"Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine","volume":"14","author":"Blum","year":"1993","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.berh.2024.101984_bib8","unstructured":"Carrara F.S.A., Piotto D.G.P., Silva I.I., Len C.A., Russo G.C.S., Chiba S.M., et al. Factors related to the readiness of Brazilian chronic pediatric patients to transition to care in adult clinics."},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cch.12110","article-title":"Walking the talk. Implementation of transitional care guidance in a UK paediatric and a neighbouring adult facility","volume":"40","author":"Shaw","year":"2014","journal-title":"Child Care Health Dev"},{"key":"10.1016\/j.berh.2024.101984_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12969-015-0016-x","article-title":"Evaluation of a rheumatology transition clinic","volume":"13","author":"Stringer","year":"2015","journal-title":"Pediatr Rheumatol Online J."},{"issue":"12","key":"10.1016\/j.berh.2024.101984_bib11","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/rheumatology\/keu257","article-title":"What does an adult rheumatologist need to know about juvenile idiopathic arthritis?","volume":"53","author":"Coulson","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.101984_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1546-0096-8-2","article-title":"High rates of unsuccessful transfer to adult care among young adults with juvenile idiopathic arthritis","volume":"8","author":"Hazel","year":"2010","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"10.1016\/j.berh.2024.101984_bib13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/rheumatology\/kep133","article-title":"The challenging adolescent","volume":"48","author":"McDonagh","year":"2009","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2024.101984_bib14","article-title":"Transition of the adolescent patient with rheumatic disease: issues to consider","volume":"33","author":"Lb","year":"2007","journal-title":"Rheumatic diseases clinics of North America [Internet]"},{"issue":"6 Pt 2","key":"10.1016\/j.berh.2024.101984_bib15","first-page":"1304","article-title":"A consensus statement on health care transitions for young adults with special health care needs","volume":"110","year":"2002","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/annrheumdis-2016-210112","article-title":"EULAR\/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases","volume":"76","author":"Foster","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib17","first-page":"1086","article-title":"Patients with juvenile idiopathic arthritis become adults: the role of transitional care","volume":"36","author":"Conti","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-021-00590-6","article-title":"Biological classification of childhood arthritis: roadmap to a molecular nomenclature","volume":"17","author":"Nigrovic","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101984_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3899\/jrheum.180922","article-title":"Juvenile idiopathic arthritis: an idea whose time has gone?","volume":"46","author":"Beukelman","year":"2019","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3899\/jrheum.120602","article-title":"Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years","volume":"40","author":"Bertilsson","year":"2013","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101984_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000304","article-title":"Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damage","volume":"2","author":"Oliveira-Ramos","year":"2016","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2020.06.020","article-title":"Comparison of paediatric and adult classification criteria in juvenile idiopathic arthritis during the transition from paediatric to adult care","volume":"88","author":"Debrach","year":"2021","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib23","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10067-022-06080-8","article-title":"The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study","volume":"41","author":"Kaya Akca","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/acr.23853","article-title":"Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort","volume":"72","author":"Glerup","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/acr.23709","article-title":"Time of disease-modifying antirheumatic drug start in juvenile idiopathic arthritis and the likelihood of a drug-free remission in young adulthood","volume":"71","author":"Minden","year":"2019","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/acr.23327","article-title":"Physical functioning, pain, and health-related quality of life in adults with juvenile idiopathic arthritis: a longitudinal 30-year followup study","volume":"70","author":"Tollisen","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-206034","article-title":"Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis","volume":"75","author":"Selvaag","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2024.101984_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3899\/jrheum.180168","article-title":"Toward new classification criteria for juvenile idiopathic arthritis: first steps, pediatric rheumatology international Trials organization international consensus","volume":"46","author":"Martini","year":"2019","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/acr.25296","volume":"76","author":"Shoop-Worrall","year":"2024","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1016\/j.berh.2024.101984_bib30","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3899\/jrheum.170794","article-title":"Predictors of flare following etanercept withdrawal in patients with rheumatoid factor-negative juvenile idiopathic arthritis who reached remission while taking medication","volume":"45","author":"Aquilani","year":"2018","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.berh.2009.08.003","article-title":"Systemic JIA: new developments in the understanding of the pathophysiology and therapy","volume":"23","author":"Vastert","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/BOR.0000000000000727","article-title":"Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?","volume":"32","author":"Klein-Wieringa","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2024.101984_bib33","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1136\/annrheumdis-2014-205265","article-title":"Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review","volume":"74","author":"van Dijkhuizen","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.berh.2024.101984_bib34","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/rheumatology\/kex265","article-title":"Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study","volume":"56","author":"Dimopoulou","year":"2017","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/acr.23236","article-title":"Health-related quality of life in an inception cohort of children with juvenile idiopathic arthritis: a longitudinal analysis","volume":"70","author":"Oen","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib36","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3899\/jrheum.180456","article-title":"Predicting which children with juvenile idiopathic arthritis will not attain early remission with conventional treatment: results from the ReACCh-out cohort","volume":"46","author":"Guzman","year":"2019","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2024.101984_bib37","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/art.40509","article-title":"Risk, timing, and predictors of disease flare after discontinuation of anti-tumor necrosis factor therapy in children with polyarticular forms of juvenile idiopathic arthritis with clinically inactive disease","volume":"70","author":"Lovell","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13075-018-1571-6","article-title":"Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study","volume":"20","author":"Rypdal","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-206034","article-title":"Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis","volume":"75","author":"Selvaag","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib40","first-page":"751","article-title":"Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis","volume":"33","author":"Esbj\u00f6rnsson","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.101984_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1546-0096-12-22","article-title":"Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA)","volume":"12","author":"Berntson","year":"2014","journal-title":"Pediatric Rheumatology Online Journal"},{"issue":"2","key":"10.1016\/j.berh.2024.101984_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3899\/jrheum.160197","article-title":"Predicting which children with juvenile idiopathic arthritis will have a severe disease course: results from the ReACCh-out cohort","volume":"44","author":"Guzman","year":"2017","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2024.101984_bib43","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/rheumatology\/key148","article-title":"Prediction of inactive disease in juvenile idiopathic arthritis: a multicentre observational cohort study","volume":"57","author":"van Dijkhuizen","year":"2018","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13075-023-03166-9","article-title":"Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes","volume":"25","author":"Oliveira Ramos","year":"2023","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib45","first-page":"819","article-title":"Treating juvenile idiopathic arthritis to target: recommendations of an international task force","volume":"77","author":"Ravelli","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2024.101984_bib46","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S2352-4642(19)30188-9","article-title":"Predicting disease outcomes in juvenile idiopathic arthritis: challenges, evidence, and new directions","volume":"3","author":"Shoop-Worrall","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"issue":"13","key":"10.1016\/j.berh.2024.101984_bib47","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2010.375","article-title":"Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial","volume":"303","author":"Foell","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.berh.2024.101984_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/art.40727","volume":"71","author":"Hinze","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2024.101984_bib49","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3899\/jrheum.111593","article-title":"ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis","volume":"39","author":"de Rotte","year":"2012","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/tpj.2014.3","article-title":"Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases","volume":"14","author":"Cobb","year":"2014","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib51","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/art.38296","article-title":"Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study","volume":"66","author":"Vastert","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib52","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/14397595.2015.1109784","article-title":"Prediction of long-term remission of oligo\/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor","volume":"26","author":"Yamasaki","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2024.101984_bib53","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3899\/jrheum.140025","article-title":"Serum interleukin 18 as a diagnostic remission criterion in systemic juvenile idiopathic arthritis","volume":"41","author":"Shimizu","year":"2014","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12969-022-00676-9","article-title":"Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis","volume":"20","author":"Soulsby","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"issue":"12","key":"10.1016\/j.berh.2024.101984_bib55","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/art.1780401219","article-title":"Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: a controlled, population-based study","volume":"40","author":"Peterson","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib56","first-page":"1039","article-title":"A longitudinal follow-up study of physical and psychosocial health in young adults with chronic childhood arthritis","volume":"27","author":"Ostlie","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2024.101984_bib57","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.10863","article-title":"Outcome in adults with juvenile idiopathic arthritis: a quality of life study","volume":"48","author":"Foster","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.berh.2024.101984_bib58","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/rheumatology\/41.12.1428","article-title":"Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome","volume":"41","author":"Packham","year":"2002","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2024.101984_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001766","article-title":"Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases","volume":"7","author":"Oliveira Ramos","year":"2021","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib60","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","article-title":"Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis","volume":"64","author":"Wallace","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13075-019-1950-7","article-title":"Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era","volume":"21","author":"Giancane","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.berh.2024.101984_bib62","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/art.21119","article-title":"Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis","volume":"52","author":"Viola","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12969-017-0151-7","article-title":"Radiographic damage in hands and wrists of patients with juvenile idiopathic arthritis after 29 years of disease duration","volume":"15","author":"Selvaag","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"10.1016\/j.berh.2024.101984_bib64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s100670050088","article-title":"Juvenile chronic arthritis in adult life: a study of long-term outcome in patients with juvenile chronic arthritis or adult rheumatoid arthritis","volume":"18","author":"Koivuniemi","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.101984_bib65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12969-021-00527-z","article-title":"Monitoring patients with juvenile idiopathic arthritis using health-related quality of life","volume":"19","author":"Doeleman","year":"2021","journal-title":"Pediatr Rheumatol Online J."},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153267","article-title":"Long-term health-related quality of life in German patients with juvenile idiopathic arthritis in comparison to German general population","volume":"11","author":"Barth","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib67","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/03009740903505213","article-title":"Self-rated physical and psychosocial health in a cohort of young adults with juvenile idiopathic arthritis","volume":"39","author":"Ostile","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2024.101984_bib68","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3899\/jrheum.180948","article-title":"Longitudinal health status from early disease to adulthood and associated prognostic factors in juvenile idiopathic arthritis","volume":"46","author":"Tollisen","year":"2019","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib69","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/ard.2004.026591","article-title":"Favourable social functioning and health related quality of life of patients with JIA in early adulthood","volume":"64","author":"Arkela-Kautiainen","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2024.101984_bib70","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","article-title":"Long-term outcome in patients with juvenile idiopathic arthritis","volume":"46","author":"Minden","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101984_bib71","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1186\/s12903-023-03510-0","article-title":"Oral health-related quality of life, impaired physical health and orofacial pain in children and adolescents with juvenile idiopathic arthritis \u2013 a prospective multicenter cohort study","volume":"23","author":"Halbig","year":"2023","journal-title":"BMC Oral Health"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib72","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12969-021-00499-0","article-title":"Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort","volume":"19","author":"Arnstad","year":"2021","journal-title":"Pediatr Rheumatol Online J."},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib73","first-page":"796","article-title":"Comorbidity profiles among adult patients with juvenile idiopathic arthritis: results of a biologic register","volume":"31","author":"Raab","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153267","article-title":"Long-term health-related quality of life in German patients with juvenile idiopathic arthritis in comparison to German general population","volume":"11","author":"Barth","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12969-023-00948-y","article-title":"Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data","volume":"22","author":"Milatz","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"10.1016\/j.berh.2024.101984_bib76","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/rheumatology\/key088","article-title":"Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study","volume":"57","author":"Hanns","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.101984_bib77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/CLEP.S45305","article-title":"Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs","volume":"5","author":"Ording","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.berh.2024.101984_bib78","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13075-018-1780-z","article-title":"Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries","volume":"20","author":"Swart","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: extra-articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.berh.2024.101984_bib80","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/rheumatology\/ket106","article-title":"Cardiovascular risk in juvenile idiopathic arthritis","volume":"52","author":"Coulson","year":"2013","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib81","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2174\/1570161118666200408121307","article-title":"Cardiovascular disease in juvenile idiopathic arthritis","volume":"18","author":"Arsenaki","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib82","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/rheumatology\/keab641","article-title":"Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries","volume":"61","author":"Kearsley-Fleet","year":"2022","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2024.101984_bib83","first-page":"691","article-title":"Systemic juvenile idiopathic arthritis","volume":"65","author":"Lee","year":"2018","journal-title":"Pediatr Clin"},{"issue":"12","key":"10.1016\/j.berh.2024.101984_bib84","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/annrheumdis-2019-216040","article-title":"Emergent high fatality lung disease in systemic juvenile arthritis","volume":"78","author":"Saper","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2024.101984_bib85","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.42137","article-title":"The conundrum of lung disease and drug hypersensitivity-like reactions in systemic juvenile idiopathic arthritis","volume":"74","author":"Binstadt","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2024.101984_bib86","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/art.41073","article-title":"Systemic juvenile idiopathic arthritis-associated lung disease: characterization and risk factors","volume":"71","author":"Schulert","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2024.101984_bib87","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3899\/jrheum.091241","article-title":"Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients","volume":"37","author":"Stagi","year":"2010","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101984_bib88","doi-asserted-by":"crossref","DOI":"10.1186\/ar4525","article-title":"Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone-mass determinants by using dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography","volume":"16","author":"Stagi","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib89","first-page":"758","article-title":"Evaluation of bone mass in children and young adults with juvenile idiopathic arthritis","volume":"33","author":"Tang","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.101984_bib90","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12969-019-0362-1","article-title":"No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis","volume":"17","author":"Hissink Muller","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.berh.2024.101984_bib91","first-page":"796","article-title":"Comorbidity profiles among adult patients with juvenile idiopathic arthritis: results of a biologic register","volume":"31","author":"Raab","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101984_bib92","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12020-023-03600-7","article-title":"Thyroid function in pediatric patients with juvenile idiopathic arthritis","volume":"84","author":"Valenzise","year":"2024","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/j.berh.2024.101984_bib93","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3899\/jrheum.190644","article-title":"Risk of diabetes mellitus in patients with juvenile idiopathic arthritis","volume":"47","author":"Lee","year":"2020","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2024.101984_bib94","first-page":"1113","article-title":"Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER Registry","volume":"34","author":"Horneff","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2024.101984_bib95","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/art.27741","article-title":"Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study","volume":"62","author":"Simard","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2024.101984_bib96","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001055","article-title":"Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapies","volume":"5","author":"Horne","year":"2019","journal-title":"RMD Open"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169422400055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169422400055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T03:34:12Z","timestamp":1727148852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169422400055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S152169422400055X"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.101984","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A lifelong journey: Long-term perspectives on Juvenile Idiopathic Arthritis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.101984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101984"}}